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Abstract: Antibacterials are among of the most important medications used in health care. 
However, their efficacy is increasingly impeded by a tremendous and globally spread 
bacterial resistance phenomenon. This bacterial resistance is accelerated by inadequate 
application of antibacterial drugs in humans, the widespread veterinary use of 
antibacterials, and antibacterial occurrence in the environment and food. Further, there is a 
lack of development of innovative novel drugs. Therefore, the search for novel 
antibacterials has to be intensified and the spread of antibacterials in the environment has 
to be restricted. Due to the fundamental progress in biosensor development and promising 
applications in the antibiotic field, this review gives for the first time an overview on the 
use and prospects of biosensor applications in that area. A number of reports have applied 
biosensors of different design and techniques to search for antibacterials in environmental 
and foodstuff matrices. These studies are discussed with respect to the analytical values 
and compared to conventional techniques. Furthermore, biosensor applications to elucidate 
the mode of action of antimicrobial drugs in vitro have been described. These studies were 
critically introduced referring to the informational value of those simulations. In summary, 
biosensors will be illustrated as an innovative and promising, although not yet 
comprehensively applied, technique in the antibacterial field. 
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1. Introduction—Bacterial Resistance, Prospects of Antibacterial Development and the Use of 
Biosensors in This Field 
Antimicrobial drugs (antibiotics either as compounds of microbiological origin, their partial 
synthetic derivatives or chemically synthesized compounds—collectively termed “antibacterials” in 
this review), more than any other class of drugs, have accounted for an increased life expectancy in 
humans. However, the efficacy of antibacterials is increasingly impeded by a tremendous and globally 
spread occurrence of bacterial resistance against these treatments—a phenomenon that arose with the 
discovery of antibacterial drugs and remains an increasing problem. Nowadays, resistance affects 
virtually all major bacterial pathogens and all types of epidemiological settings. As an example of the 
situation worldwide, Figure 1 shows the progress of selected resistant bacterial strains in Central and 
Southern Europe between 2002 and 2009 (data collected by the European Antimicrobial Resistance 
Surveillance System, EARSS [1]). 
Figure 1. Progress of selected resistant bacterial strains in Central and Southern Europe 
between 2002 and 2009. The amount of resistant isolates increased slowly but constantly 
over the years. 
 
 
During continuous exposure to antibacterials, sequential chromosomal mutations can occur, leading 
to the appearance of resistance mechanisms step by step [2,3]. Several factors contribute to the 
occurrence of bacterial resistance: (i) the inappropriate use/misuse of antibacterials in humans; (ii) the 
veterinary use of antibacterials in pets, farm animals and animals raised in aquaculture [4]; and (iii) the 
increased occurrence of antibacterials or their metabolites contaminating the environment, mainly 
resulting from the latter applications. 
To ensure the efficiency of antibacterial treatments in the near future, the further development of 
bacterial resistance has to be stopped, i.e., by reducing the contamination of the environment with 
antibiotics. Furthermore, it is equally important to develop novel antibacterials or to identify natural 
compounds that can overcome the existing resistance mechanisms or attack novel target structures. 
The development of new antibacterial substances, however, is still a problem. For example, despite the 
fact that lower respiratory infections were the third leading cause of death worldwide in 2008 and the 
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leading cause in low-income countries [5], many pharmaceutical companies have withdrawn 
completely from antibacterial drug discovery because the development of new drugs is increasingly 
expensive before getting approval. Once new entities reach the market, it is difficult to recoup the costs 
of development, which is especially true for antibacterials due to their mainly short time application 
intervals [6]. This is reflected in the time scale of antibacterial development (Figure 2). 
Figure 2. The timeline of antibacterial development modified from Wright [7]. 
Antibacterial development started in the 1930s with the sulfonamides, followed by a period 
of 40 years with successful antibacterial discovery. After a long period in which no real 
novel antibacterials were discovered, only a few new antibacterial classes were identified 
in the current millennium. 
 
Until the early 1980s different antibacterial classes were identified. Then, until the end of the   
20th century, there was no further development of real novel antibacterials, which strengthens the 
present efforts to find novel modes of action or to attack hitherto unknown target structures [7]. In 
recent years three novel antibacterials (the lipopeptide daptomycin [8], the glycylcycline tigecycline [9] 
and the pleuromutilin antibacterial retapamulin [10]) have been approved. All other approved 
antibacterials are more or less derivatives of known ones. Moreover, there are presently only five real 
novel antibacterial agents in clinical development, necessitating the search for new sources, such as 
marine natural products or for new bacterial targets in plasma and outer membrane, cell wall, 
ribosomes, nucleoid, or plasmids. 
The following review will highlight biosensors as useful tools in the antibacterial research field, 
their usefulness to fight against the spread of bacterial resistance, and the development of new 
antibacterial compounds. The number of biosensor approaches in this area has increased during the last 
five years, dominated by studies for the detection of antibacterials in the environment [Figure 3(A)]. In 
the first part of this review a number of studies, which have applied different biosensor methods to 
detect antibacterials in various matrices with the intention to stem resistance developments, will be 
interpreted and evaluated with respect to the technical merits and prospects. Sensors 2011, 11  9453 
 
Figure 3. Biosensor applications in the antibacterial field are classified regarding to (A) 
their experimental approaches, and (B) the detection principles. (A) Nearly 60% of the 
biosensor applications contribute to detection or quantification of antibacterials in the 
environment as a basis for interference with the increasing bacterial resistance; (B) Nearly 
half of the detection principles are based on surface plasmon resonance technique. 
 
The second part focuses on the use of biosensors in mode of action studies of novel antibacterials. 
Although there are fewer studies for the latter application [Figure 3(A)], the prospects of biosensors to 
participate in drug development are certain. 
It must be noted that this review can only give an instantaneous view in the current situation of 
biosensor application in the antibacterial field. The given information (especially that in Figure 3) is 
based on the availability of published data [11]. However, the authors cannot exclude the existence of 
much more, as yet unpublished applications of biosensors mainly in the field of industrial antibacterial 
development. As mentioned before, the development of new antibacterials before approval is a slow 
and strictly regulated process. One can assume that the number of applications of biosensor techniques 
in the search for new antibacterials is higher than demonstrated by the authors. Nevertheless, this 
review and the data therein are restricted to already published data and, in the case of the antibacterial 
timeline (Figure 2), to approved drugs. 
2. Biosensor Application to Detect Antibacterials in Environment and Food as Contribution to 
Prevent Bacterial Resistance 
2.1. General 
The growing incidence of resistant bacteria due to inadequate medical or veterinary treatment 
regimens is greatly intensified by the subsequent appearance of antibacterials in the environment. 
Environmental accumulation and pollution is not only a problem of antibacterials, but also relevant for 
different biologically active compounds in general (drugs, drug metabolites or endocrine disruptors). 
Due to bacterial adaptation and resistance formation, antibacterials merit special attention. The 
analysis of drinking water is of special interest in this context given the different pathways and 
possibilities to place potential pollutants into aquatic circulation. However, there are no standardized Sensors 2011, 11  9454 
 
analytical methods for aquatic pollutants. Nowadays the main analytical tools are liquid and gas 
chromatographic techniques, mostly combined with mass spectrometric analysis. For detailed 
information on current analytical techniques for the detection of aquatic pollutants, the reader is 
referred to reviews in this field ([12-18] and the references therein). The analysis of antibacterials, for 
example, in environmental waters is usually performed by HPLC-MS or HPLC-MS/MS. Other 
methods, such as UV or fluorescence spectroscopy or electrochemical detection are of minor 
importance due to their lower sensitivity. 
Since antibiotics are given to animals for therapy and prophylaxis as well as to increase growth and 
feed efficiencies [4], the proof and control of antibiotics in animals and foodstuffs of animal origin is 
essential. In the food industry milk is one of the most heavily regulated products. Due to their 
lipophilic properties, antibacterials can easily accumulate in higher amounts in milk. The widespread 
usage of milk makes it necessary to control threshold levels of antibacterials in milk. It is essential  
to detect the antibacterials prior to a contamination of the food chain event, e.g., at the farm. Therefore 
analytical methods for simple and speedy detection are necessary. 
It is well known that the above mentioned “conventional” analytical methods are elaborative with 
respect to sample preparation (pre-treatment, clean-up and concentration), costs and time consumption 
and often require personal expertise and skills. The ongoing development of biosensors opens a 
promising new way to enable the use of fast, simple and sensitive techniques to detect environmental 
pollution by antibacterials or their appearance in food products.  
The application of biosensors as tools to detect pathogens is beyond the scope of this review. 
Besides the analysis of pathogens in the human organism, such as analysis of Chlamydia trachomatis 
in urine using optical biosensors [19] or causative organisms of dengue fever using quartz crystal 
microbalance (QCM) [20], the detection of e.g., pathogen-infected foodstuffs is essential. Examples of 
biosensor applications are the detection of aflatoxin in milk samples [21], the detection of E. coli 
O157:H7 in food samples [22] or the use of a cell based biosensor technique to detect various numbers 
of pathogens and toxins [23]. 
Biosensors as detection tools for antibacterials clearly differ in the sensor system, the principle of 
sample recognition as well as in the type of matrix. The different recognition and detection principles 
will be pointed out below.  
2.2. Recognition and Detection Principles for the Biosensor Based Detection of Antibiotics 
In general, there are two main principles for the recognition of antibacterials by biosensor systems. 
The first one comprises the widespread use of immobilized aptamers as recognition elements   
(so called aptasensors) [24-27]. RNA and DNA aptamers are oligonucleic acids that bind the analyte of 
interest by their 3D-structure via ionic interaction, van-der-Waals-forces or hydrogen bonds leading to 
detectable signals. Their sensitivity is comparable to that of antibodies. Furthermore they can be 
chemically synthesized, possess a high thermal stability and are easy to modify and to immobilize. The 
second principle of antibacterial recognition for biosensing is given by antibody-mediated binding 
processes. Those immunosensors have been widely used for antibacterial detection [28-34]. It is either 
possible to immobilize antibiotic-specific antibodies at the sensor surface to directly detect the Sensors 2011, 11  9455 
 
antibiotic binding, or to invert the assay and detect the binding of antibody-spiked samples onto 
immobilized antibiotics in terms of a competitive assay. 
Beside aptamers and immunoassay-based recognition, other principles have to be mentioned, e.g., 
the use of enzymes or functionalized gold nanoparticles or the application of whole bacterial cells as 
recognition elements.  
Referring to enzyme-coupled principles, a number of studies have reported on the immobilization of 
β-lactamase for the in vivo detection of penicillins [35-37]. Hydrolysis of the penicillins led to a decrease 
in the pH value, which was amperometrically detected by Chen et al. [37], amongst others in milk samples. 
A very interesting recognition approach is the use of functionalized gold nanoparticles. 
Frasconi et al.  [38] protected gold nanoparticles with thioaniline (as electropolymerizable unit), 
mercaptophenylboronic acid (as ligand for antibiotics) and mercaptoethanesulfonic acid (for 
nanoparticle stabilization). The polymerization of these functionalized nanoparticles on a gold surface 
was followed by SPR in the presence of aminoglycosides (neomycin, kanamycin, streptomycin) and 
used as a sensor for antibacterial detection in milk samples. SPR signals are amplified by the use of 
nanoparticles and thus, the sensor sensitivity is increased.  
In contrast to the above mentioned technical biosensor devices, a number of studies also referred to 
“biosensing” antibacterials using whole bacterial cells with specific detection and sensing mechanism 
for certain antibacterials. One example is given by Virolainen et al. [39], who introduced an E. coli 
bacterial strain containing a luciferase operon placed under control of a tetracycline response element. 
Therefore, these bacteria, which can be kept in a freeze-dried form, produce self-bioluminescence 
following tetracycline recognition. The evaluation can be performed in a plate assay format as an 
essential prerequisite for a rapid, inexpensive high-throughput screening system. The authors described 
the detection of different tetracyclines in poultry muscle tissue in the low ng/g range meeting the 
demands of the maximum residue levels (MRL) of the European Union. A follow-up study, which 
compared the capacity of the bacterial sensor with microbiological inhibition assays or LC-MS/MS 
detection of tetracyclines in routine analyses of poultry samples, confirmed the value and applicability 
of this approach [40]. 
Despite many different antibacterial recognition principles that can be used for biosensor applications, 
only a limited number of biosensor techniques were used in the antibiotic field. Figure 2(B) illustrates 
the most common methods for analyte detection in that area. Some 50% of the biosensors used are 
based on the SPR technique. SPR can be upgraded by imaging methods (iSPR) to get more details on 
the antibacterial binding process [32,41]. 
Optical detectors that are different from SPR account for about one fifth of antibacterial detection. 
Alongside the already mentioned detection of luminescence after antibiotic binding, fluorescence 
measurements were also applied [28,35]. 
Electrochemical methods (21%) are the second most used detection principles beside SPR. They  
are dominated by voltammetric (cyclic voltammetry/CV or square wave voltammetry/SWV) and 
amperometric methods. Thereby a reduced Faradaic current is detected after antibiotic binding. The 
antibacterial layer impedes the electron transfer acting as an electrode isolating layer. Since antibacterials 
are most often not electrochemically active by themselves, redox tags like hematein, methylene blue or 
the commonly used Fe
2+/Fe
3+ system have to be added. Impedance spectroscopy as an electrochemical 
detection method was also described and works without redox tags. Sensors 2011, 11  9456 
 
In principle there are versatile ways to combine the different recognition and detection principles. 
However, some combinations are more common in the antibiotic field. For instance, the binding of 
antibiotics to aptamers is often detected by electrochemical methods (CV and SWV). Zhang et al. and 
Kim et al. used DNA aptamers for the detection of tetracycline and oxytetracycline. Zhang et al. [24] 
coupled a tetracycline binding ssDNA-aptamer via EDC/NHS-chemistry on a glassy carbon electrode. 
Cyclic voltammograms of defined tetracycline concentrations were recorded in the presence of redox- 
active K3[Fe(CN)6]. The correlation between increasing tetracycline concentrations and decreasing 
current peaks (due to an increasing isolation of the electrode) was used for fast detection of   
unknown tetracycline concentrations in milk. Kim et al. [25] immobilized an oxytetracycline binding  
ssDNA-aptamer with high affinity, while the binding of other tetracyclines was discriminated. Since 
the aptamers was thiol modified, immobilization could easily be performed occurred via covalent 
chemistry on a gold electrode. CV and SWV were applied to determine oxytetracycline concentrations. 
RNA aptamers were applied by Rowe et al. [26] to electrochemically detect the concentration of 
aminoglycoside antibiotics in blood samples in order to prevent overdosage and side effects. 
Aminoglycoside binding RNA aptamers were immobilized on a gold electrode. To avoid fast degradation 
during application in blood samples, the aptamers were modified by methylation of all 2’-hydroxyl 
groups outside the antibiotic binding pocket. As an alternative, more degradation-resistent DNA-aptamers 
were applied. SWV experiments showed a lower sensitivity of the DNA-aptamer based sensor to 
detect aminoglycosides in blood samples compared to RNA-based sensor. 
Electrochemical detection was also combined with immunosensor based recognition. For example, 
Ionescu et al. [33] immobilized anti-ciprofloxacin antibodies onto a polypyrrole-NHS-film. A positive 
interaction with ciprofloxacin was detectable by changes in the impedance spectrum. As an alternative 
assay, ciprofloxacin was immobilized on the polypyrrole-NHS-layer and covered with ciprofloxacin 
antibodies by Giroud et al. [29]. Since ciprofloxacin from a sample solution binds to the antibody with 
a higher affinity compared to the immobilized derivatives, the resulting removal of the antibodies 
relates to the sample ciprofloxacin concentration, which can be monitored and even quantified by 
recording the impedance spectra. This approach corresponds to a competitive immunoassay. 
A very common combination is the immunosensor based recognition of antibacterials followed by 
an SPR based detection–a fact that might be due to the broad spread of both. The competitive 
immunoassay as biosensor recognition element has, for example, also been applied by Dong et al. [30] 
for the detection of chloramphenicol in pork. Ferguson et al. [34] immobilized a streptomycin derivative 
and analyzed the competitive binding of a mixture of streptomycin and an anti-streptomycin-antibody. 
Thus, the quantitative analysis of streptomycin and dihydrostreptomycin in honey, milk and meat 
became possible. Both used SPR as detection method. SPR as the most common detection method was 
also combined with aptamer recognition. The aminoglycoside neomycin B was also detected with the 
help of an RNA aptamer by de-los–Santos-Alvarez et al. [27]. 
2.3. Biosensor Tools to Detect Antibiotics in Food 
After introducing the different recognition and detection principles, this chapter will present 
biosensors as fast and easy-to-use devices for the detection of antibacterial residues in milk and other 
food products. These devices exceed traditional time-consuming monitoring methods and are sensitive Sensors 2011, 11  9457 
 
enough to detect antibiotic concentrations below the maximum residue levels (MRL), which have been 
defined by the European Union. Due to the EU Council Regulation No 2377/90 the “maximum residue 
levels” are defined as “the maximum concentration of residue resulting from the use of a veterinary 
medicinal product which may be accepted by the community to be legally permitted or recognized as 
acceptable in or on food. It is based on the type and amount of residue considered to be without any 
toxicological hazard for human health as expressed by the acceptable daily intake [42]”. Here “food” 
comprises all the various foodstuffs of animal origin, including meat, fish, milk, eggs and honey. 
MRLs were established for many antibacterials and their adherence has to be controlled by suitable 
and sensitive analytical techniques. 
Rebe Raz et al. [41] reported on the simultaneous quantification of up to seven antibiotics from 
different families in buffer or milk by implementing a microarray immunoassay in an imaging surface 
plasmon resonance platform. On the basis of NHS/EDC chemistry the authors immobilized 
sulfamethazine, neomycin, gentamicin, streptomycin, kanamycin, chloramphenicol, and entrofloxacin 
on a SPR sensor with the help of a microspotter. The assays’ sensitivity and specificity were controlled 
by following the binding of the corresponding antibodies. Although the SPR signals were comparably 
low, they clearly demonstrated specific antibody binding with low cross reactivity (Figure 4).  
Figure 4. ( A) SPR image of antibody binding onto different immobilized antibiotics 
(neomycin/NEO, gentamicin/GNT, kanamycin/KAN, dihydrostreptomycin/DHS, 
norfloxacin-NH2 derivative/NOR-NH2, chloramphenicol/CAP, and sulfamethazine/SMZ. 
(B) Sensorgramms display specific antibody recognition with low cross reactivity 
(reprinted with permission from Rebe Raz, S.; Bremer, M.G.E.G.; Haasnoot, W.; Norde, 
W. Label-free and multiplex detection of antibiotic residues in milk using imaging surface 
plasmon resonance-based immunosensor. Anal. Chem. 2009, 81, 7743-7749. Copyright © 
2009, American Chemical Society). 
 
The validated sensor was then used to follow the inhibition of the antibody binding in a competitive 
format by the relevant antibiotics in the test solutions. The mentioned antibiotics in both buffer (HBS) Sensors 2011, 11  9458 
 
or 10-time diluted milk were quantified in the low ng/mL range (IC50 values), whereas a uniform 
matrix effect of the milk constituents was not evident. The calculation of the limit of detection showed 
sensitivity in the ppb-range, which was sensitive enough for milk control at the MRL level established 
in the EU for neomycin, kanamycin, streptomycin, entrofloxacin, and sulfamethazine. This rapid and 
label-free detection of antibiotics from the aminoglycoside, fluoroquinolone, phenicol, and sulfonamide 
family opened the perspective for an automated and high-throughput monitoring of antimicrobial drug 
residues in food. 
A comparable approach to detect different antibiotics in milk using an SPR device has recently 
been reported by Fernandez et al. [43]. The focus was the establishment of a compact and portable 
device with a six channel configuration suitable for on-site applications. Haptenized proteins were 
immobilized by the EDC/NHS coupling procedure in the different channels and enrofloxacin, 
sulfapyridine, and chloramphenicol were detected as representatives of the fluoroquinolones, 
sulfonamides, and phenicols, respectively, by adding the respective polyclonal antibodies to the 
samples. Matrix effects of milk could simply be reduced by five-time dilution of the milk with buffer. 
No further pre-processing steps of sample preparation were needed. A very good degree of 
repeatability of detection on consecutive cycles with coefficients of variation below 5% was reported. 
The limit of detection of enrofloxacin and sulfapyridine in the low µg/kg range was far below the 
MRL and for chloramphenicol slightly superior to the MRL. It was considered that the SPR device has 
identical analytical capacities compared to other commercially available SPR systems and approaches 
in this field [41,44,45] but additionally offers the advantage of compactness and mobility. With respect 
to the group-selectivity of the used immunoreagents, a much higher number of antibiotics from the 
included families appear to be detectable with this analytical approach. 
A similar approach of milk analysis, but using an alternative biosensor system has been reported by 
Adrian et al. [46]. An immunosensor on the basis of a wavelength interrogated optical sensing device 
in a flow chamber system was developed to detect the binding of sulfonamides with immobilized 
immunoreagents. Sulfapyridin as reference was detectable at a low µg/L level, and milk samples 
contaminated with different sulfonamides were identified according to the MRLs of the EU. The same 
technique has been applied to develop a multiplexed biosensor to detect sulfonamides, fluoroquinolones, 
and tetracyclines in raw milk [47]. 
Referring to SPR analysis of antibacterials in other food matrices, Huet et al. [48] reported on the 
development of an immunochemical screening method based on SPR for the detection of 13 different 
fluoroquinolones with special focus on flumequine in egg, fish, and poultry meat. A bi-active antibody 
for immune recognition was prepared and enables the detection of 13 different fluoroquinolones at 
levels below their established MRLs after a simple liquid extraction procedure. Comparison with 
conventional analytical approaches (LC-MS/MS) in this study and a follow-up study including the 
microbiological assays [49] confirmed similar sensitivity of this biosensor method and the potential as 
a routine analysis of fluoroquinolones in the mentioned matrices. 
In a similar approach, the validation of a Biacore-based system for detection of sulfonamides in 
porcine, bovine and poultry muscle was reported [50]. The performance characteristics of the system 
were evaluated with respect to the MRL demands of the EU and found to be sufficient with respect to 
the detection limits, but also to precision and applicability. Sensors 2011, 11  9459 
 
The selected examples justify the conclusion that biosensors are suitable and very promising tools 
for the search of antibacterials in the environment and appear as an important component to stem the 
distribution of bacterial resistance. Despite many different techniques that could be used as biosensor 
detection principles, only a limited number of principles are presently used in the antibiotic field with  
a dominance of the SPR technique. Other optical as well as electrochemical detection principles also 
contribute to antibiotic recognition whereas, for example, mass sensitive biosensors are underrepresented 
in this area. Compared to conventional analytical methods, biosensors can be applied as fast, simple 
and cost efficient methods that can even be used without further sample preparation. The examples 
discussed above show that the detection limit is comparable to that of conventional analytical methods 
and fulfils the criteria threshold values of common regulatory requirements and the MRL rules of the EU. 
However, the data does not allow a final conclusion whether biosensors presently have potential as 
a high throughput screening application. Promising biosensor developments with strict orientation for 
high throughput applications, such as the kinexa systems, for the detection of pollutants in the aqueous 
environment as example [51], have not been described in the antibiotic field. 
3. Biosensor Applications to Elucidate the Molecular Mode of Action 
3.1. General 
In order to fight bacterial resistance it is equally important to develop novel antibacterials and to 
identify natural compounds that can overcome the existing resistance mechanisms or to attack new 
target structures. In addition to the previously mentioned control and detection of antibacterials in the 
environment, biosensors can also add to the search for novel targets and simulated processes of 
antibacterial activities. The following section will provide a summary of studies where biosensors, 
mostly SPR and mass sensitive biosensors, were applied to obtain further insights into the mode of 
action of established or experimental antibacterials or in the search of bioactive natural compounds. 
3.2. Mode of Action Studies on Host Defense Peptides 
The molecular mode of action (MoA) of antibacterials is often manifold and complex and can 
therefore not be simply analysed using a single technique. In general, the classical microbiological 
assays to detect the bacterial killing kinetics (MIC values) are the essential prerequisite and selection 
criterion for further detailed studies. Biosensors can contribute to the elucidation of antibacterial activities, 
i.e., when postulations on target structures exist. Biosensors are most likely promising tools to validate the 
binding or interaction of antibacterials with bacterial components, such as membrane constituents, to 
participate in the target validation process. Some of those studies will be introduced in the following 
section. Livne et al. [52] characterized OAK sequences (oligo-acyl-lysyl) of host defense peptides and 
identified a promising candidate (C12K-3β10). This peptide in general showed broad-spectrum activity 
against bacteria with activity twice as high against Gram-positive bacteria (S. aureus) compared to 
selected Gram-negative bacteria. In order to ascertain, whether these differences in the MIC are related 
to different peptide-membrane interactions, model membranes were used to mimic the characteristics 
of Gram-positives by a phosphatidylglycerol (PG):phosphatidylethanolamine (PE) mixture or of 
Gram-negatives by an PG:cardiolipin (CL) mixture. SPR was applied to determine the binding kinetics Sensors 2011, 11  9460 
 
of C12K-3β10 to both membranes. The OAK was shown to have a higher affinity to the PG:PE 
membrane. Livne et al. proposed a deeper disruption of the membranes through the higher affinity, 
which would explain the lower MIC values of C12K-3β10 against S. aureus. 
SPR was also used in elucidating the mode of action of oyster defensins. Defensins belong to the 
group of antimicrobial peptides (AMPs). Due to their cationic and hydrophobic nature, AMPs are 
thought to act by permeabilization of the bacterial membrane in a target independent way. However, 
Schmitt et al. [53] showed oyster defensins (Cg-Defm, Cg-Defh1 and Cg-Defh2) to use the cell wall 
precursor lipid II as defined target structure for their activity. Beside different in vivo and in vitro 
assays (amongst others lipid II precursor accumulation assays), SPR was applied to determine the 
defensins’ binding affinity to target free DOPC vesicles compared to that of DOPC/lipid II. Whereas 
nearly no binding of the oyster defensins was observed on DOPC vesicles, all of them significantly 
bound to DOPC/lipid II vesicles, thus confirming the essential role of the cell wall precursor in the 
oyster defensing mode of action. 
3.3. Mass Sensitive Biosensors as Contribution to Mode of Action Studies 
Mass sensitive sensors, such as quartz crystal microbalance (QCM) or the closely related surface 
acoustic wave sensor (SAW) have been applied in a number of studies in combination with model 
membrane approaches. Both techniques are based on the relationship between mass increase on a 
quartz crystal and a decrease in quartz crystals’ oscillation frequency. This enables the detection of the 
intensity and mode of membrane interaction of different peptide antibacterials and thus simulates their 
postulated activities at bacterial membranes. 
Lipopeptides, like friulimicin, are anionic charged molecules with amphipathic characteristics and 
show distinct activities against Gram-positives. The leading substance daptomycin is mainly thought to 
interact with and disrupt bacterial membranes. Due to its net negative charge and in contrast to the 
AMPs discussed earlier this has to be mediated by divalent cationics like Ca
2+. However, the structural 
related friulimicin was shown to not only interfere with the bacterial membrane but also to inhibit cell 
wall biosynthesis by complexation of the bactoprenol phosphate carrier C55-P in a calcium dependent 
manner [54]. Although the calcium-dependency of friulimicin was known, the role of calcium ions 
remained to be clarified.  
QCM studies on friulimicin binding to model membranes not only confirmed C55-P as a target 
structure but also identified the phosphate of C55-P as an essential moiety for friulimicin binding. 
Calcium was shown to act as a bridge between the peptide and the phosphate and was further shown to 
affect the peptide-peptide interaction before binding to the membrane. Yet, the ability of QCM to 
analyze the peptide-peptide interaction in the presence of Ca
2+ was limited. Further techniques (atomic 
force microscopy and circular dichroism spectroscopy) were necessary to show that calcium influences 
the conformation of friulimicin thus enabling the peptide to bind to the membrane [55]. 
However, QCM and SAW are highly suitable for the determination of kinetic constants of 
antibacterial binding to model membranes and thus target validation. The determination of association 
and dissociation rates as well as the overall binding constant KD can help to elucidate the target mediated 
as well as nonspecific mechanisms in detail that both contribute to the antibiotic mode of action.  Sensors 2011, 11  9461 
 
The binding constants of lantibiotics were the focus of several studies. Lantibiotics are amphiphilic 
peptides with intramolecular ring structures that inhibit cell wall biosynthesis by binding lipid II. This 
mode of action is partly combined with pore forming properties. The use of QCM analysis revealed the 
lantibiotic nisin to have a much higher binding affinity to model membranes in the presence of lipid II 
compared to plain membranes (KD 0.27 µM vs. 1.03 µM) mainly due to a much stronger association 
of nisin (kass 4,677 M
−1 s 
−1 vs. 752 M
−1 s
−1). The combination with CV measurements illustrated the 
pore forming activities of nisin in dependence of lipid II [56]. 
The lantibiotic gallidermin was shown to interact with lipid II containing membranes (KD 0.28 µM) 
with activity comparable to that of nisin. Furthermore, gallidermin interacts with a similar intensity 
with lipid II free membranes (KD 0.27 µM), which contributes to the antibiotic activity in dependence 
on the membrane composition [57]. The detailed analysis of SAW measurements, illustrating the 
changes in phase and amplitude of surface acoustic waves, confirmed the lipid II recognition in 
parallel to gallidermin membrane insertion and resulting membrane rigidification (Figure 5).  
Figure 5. Illustration of SAW measurements. The changes in phase (A) and amplitude (B) 
of surface acoustic waves confirmed the lipid II recognition (dotted line in (A)) in parallel 
to gallidermin membrane insertion and a resulting membrane rigidification (increase in 
amplitude in (B) at the dashed or dotted line, resp.) (reprinted with permission from Al-
Kaddah, S.; Reder-Christ, K.; Klocek, G.; Wiedemann, I.; Brunschweiger, M.; Bendas, G. 
Analysis of membrane interactions of antibiotic peptides using ITC and biosensor 
measurements. Biophys. Chem. 2010, 152, 145-152. Copyright © 2010, with permission 
from Elsevier). 
 
 
This illustration helped to interpret the biological MIC data. However, the mass sensitive sensors 
alone were not sufficient enough to fully elucidate the target independent interaction with model 
membranes. Therefore, SAW was combined with isothermal titration calorimetry (ITC) to finally 
reveal that the insertion of gallidermin into the membrane and the resultant influence on the dynamic 
membrane properties is a serious contribution to the gallidermin activity [58]. The above mentioned Sensors 2011, 11  9462 
 
studies illustrate that biosensors are useful tools to elucidate the antibiotic mode of action of different 
compounds. However, due to the complexity of biological mechanisms, biosensors can only contribute 
to the elucidation of antibiotic activities, most likely by simulating membrane processes, but cannot be 
used alone for mode of action studies. For example, Figure 6 illustrates a useful combination of 
biosensor techniques with other analytical methods in case of gallidermin membrane interaction. 
Figure 6. Biosensors’ contribution to the mode of action studies of gallidermin. Whereas 
the biosensor techniques QCM and SAW allow for the detection of binding kinetics 
(targeted and untargeted), additional techniques like ITC were necessary to provide 
evidence for non-targeted membrane activities of gallidermin in synergy with lipid II 
mediated interactions (reprinted with permission and minor modifications from Al-
Kaddah, S.; Reder-Christ, K.; Klocek, G.; Wiedemann, I.; Brunschweiger, M.; Bendas, G. 
Analysis of membrane interactions of antibiotic peptides using ITC and biosensor 
measurements. Biophys. Chem. 2010, 152, 145-152. Copyright © 2010, with permission 
from Elsevier). 
 
4. Conclusions 
The present review focused on the use of biosensors to mitigate the spread of bacterial resistance. 
Since about two thirds of biosensor applications in the antibacterial field contribute to the detection of 
antibiotics in the environment or foodstuffs, this aspect has been especially emphasized. Only a limited 
number of recognition and detection principles have been used in this field. However, biosensors were 
found to be comparable to conventional methods with respect to sensitivity and specificity of 
antibacterial detection and thus fulfill international regulatory requirements. Since biosensors offer 
fast, simple and cost efficient methods that can even be used without additional sample preparation, Sensors 2011, 11  9463 
 
they offer evident advantages compared to conventional analytical techniques and will therefore hold 
great promises for a much wider application in the near future. 
In addition, a number of studies suggest that biosensors could add to the complex research to 
elucidate the mode of action of new antibacterial substances. However, biosensor applications for 
mode of action studies are presently limited to SPR and mass sensitive techniques (QCM, SAW) and 
dominated by the detection of kinetic binding constants of drugs or drug candidates towards their 
postulated targets or simulated bacterial membranes. Further studies have to justify whether biosensors 
will have a stronger impact on the evaluation of molecular mechanisms of antibacterial compounds. 
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